Concepedia

Kara M. Schenk

KM

Statistics

Publications

4

Citations

201

H-Index

4

Active since

2019

Affiliations

Sidney Kimmel Comprehensive Cancer Center(Current)

Johns Hopkins University

Johns Hopkins Hospital

National Cancer Institute

Johns Hopkins Medicine

Kara M. Schenk is an author at Sidney Kimmel Comprehensive Cancer Center specializing in kidney transplant, pharmacotherapy, and cancer research.

ORCID

Top concepts

Publications per year

2019–2024

4

Publications

4

<i>ZCCHC8</i>, the nuclear exosome targeting component, is mutated in familial pulmonary fibrosis and is required for telomerase RNA maturation

Dustin L. Gable, Valeriya Gaysinskaya, Christine C. Atik et al. · Genes & Development · 2019 · 117 citations · Full text

Nivolumab + Tacrolimus + Prednisone ± Ipilimumab for Kidney Transplant Recipients With Advanced Cutaneous Cancers

Kara M. Schenk, Julie S. Deutsch, Sunandana Chandra et al. · Journal of Clinical Oncology · 2024 · 46 citations · Full text

Spatial UMAP and Image Cytometry for Topographic Immuno-oncology Biomarker Discovery

Nicolás A. Giraldo, Sneha Berry, Étienne Becht et al. · Cancer Immunology Research · 2021 · 22 citations · Full text

Nivolumab (NIVO) + tacrolimus (TACRO) + prednisone (PRED) +/- ipilimumab (IPI) for kidney transplant recipients (KTR) with advanced cutaneous cancers.

Kara M. Schenk, Julie E. Stein, Sunandana Chandra et al. · Journal of Clinical Oncology · 2022 · 16 citations

, , +23

1–4 of 4